Ryvu Therapeutics (FRA:9Y4) Marketable Securities : €15.21 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ryvu Therapeutics Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Ryvu Therapeutics's Marketable Securities for the quarter that ended in Dec. 2024 was €15.21 Mil.

Ryvu Therapeutics's annual Marketable Securities increased from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€40.78 Mil) but then declined from Dec. 2023 (€40.78 Mil) to Dec. 2024 (€15.21 Mil).

Ryvu Therapeutics Marketable Securities Historical Data

The historical data trend for Ryvu Therapeutics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ryvu Therapeutics Marketable Securities Chart

Ryvu Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

5.81

1.16

40.78

15.21

Ryvu Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial															40.78	26.85	32.87	16.42	15.21

Ryvu Therapeutics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Ryvu Therapeutics (FRA:9Y4) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Ryvu Therapeutics Marketable Securities Related Terms

Thank you for viewing the detailed overview of Ryvu Therapeutics's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ryvu Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ryvu Therapeutics SA (FRA:9Y4) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

RVU:Poland 9Y4:Germany

Address

Leona Henryka Sternbacha 2, Krakow, POL, 30-394

Website

https://www.ryvu.com

Ryvu Therapeutics SA is a company which is engaged in discovering and developing small molecule therapies that address oncology. Its product candidate SEL120, is a kinase inhibitor with potential for development in hematological malignancies and solid tumors. The pipeline products of the company are developed in the areas of kinases, cancer metabolism, synthetic lethality, and immuno-oncology pathways.

Ryvu Therapeutics Headlines

No Headlines